Home / Gabapentin / Germany
DE ATC N03AX12 · updated 2 Nov 2026
Gabapentin shortage in Germany
Is there a Gabapentin shortage in Germany?
Yes. As of 2 Nov 2026, 11 Gabapentin products are reported short in Germany, the first since 4 Jul 2025. The company estimate for the return is 31 Dec 2026. Main reason: manufacturing problem.
Not reported short in any other country we track. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Gabapentin Holsten 300 mg Hartkapseln | Holsten Pharma GmbH - Geschäftsanschrift - | 4 Jul 2025 | 31 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Gabapentin Holsten 800 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 17 Jul 2025 | 31 Dec 2026 | Manufacturing problem Herstellerwechsel |
| DE | Gabapentin Holsten 800 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 17 Jul 2025 | 31 Dec 2026 | Manufacturing problem Herstellerwechsel |
| DE | Gabapentin Holsten 800 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 17 Jul 2025 | 31 Dec 2026 | Manufacturing problem Herstellerwechsel |
| DE | Gabapentin Holsten 100 mg Hartkapseln | Holsten Pharma GmbH - Geschäftsanschrift - | 1 Aug 2025 | 31 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Gabapentin Holsten 100 mg Hartkapseln | Holsten Pharma GmbH - Geschäftsanschrift - | 1 Aug 2025 | 31 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Gabapentin Holsten 100 mg Hartkapseln | Holsten Pharma GmbH - Geschäftsanschrift - | 1 Aug 2025 | 31 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Gabapentin Holsten 600 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 21 Aug 2025 | 31 Dec 2026 | Manufacturing problem Herstellerwechsel |
| DE | Gabapentin Holsten 600 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 21 Aug 2025 | 31 Dec 2026 | Manufacturing problem Herstellerwechsel |
| DE | Gabapentin Holsten 600 mg Filmtabletten | Holsten Pharma GmbH - Geschäftsanschrift - | 21 Aug 2025 | 31 Dec 2026 | Manufacturing problem Herstellerwechsel |
| DE | Gabapentin Holsten 400 mg Hartkapseln | Holsten Pharma GmbH - Geschäftsanschrift - | 20 Oct 2026 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.